Contrasting LBAs and LC-MS for Peptide and Protein Bioanalysis

1,803 views

|

May 4, 2018

Kelly Doering discusses ligand binding assays (LBAs) and compares the advantages and limitations of this technology to LC-MS. She'll then present three examples of when LC-MS is the preferred method for quantification of insulin analogs based on specificity requirements and the need to multiplex.

ChromatographyDrug DiscoveryMicrofluidicsProteomics and Metabolomics

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.